Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mechanistic Inflammatory Pathways in Graft Versus Host Disease

Award Number: R01HL154579
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2020
PERIOD OF PERFORMANCE END DATE: 05/31/2026

Group Awards By:

View Award Description

Mechanistic Inflammatory Pathways in Graft Versus Host Disease - PROJECT SUMMARY Graft versus host disease (GVHD) is the major complication associated with allogeneic hematopoietic stem cell transplantation (HSCT). Pathological damage to the skin, gastrointestinal tract, and liver are hallmarks of this disease; however, GVHD can also induce inflammation in the central nervous system (CNS) as well as cognitive and behavioral alterations in patients. We previously observed that host interleukin 6 (IL-6) production and the associated expansion of CNS resident macrophages (microglia) appear to have critical roles in the induction of neuroinflammation, but that blockade of IL-6 signaling does not completely mitigate disease severity. In preliminary studies, we have now identified endocannabinoid signaling through the type 2 cannabinoid receptor (CB2R) and the kynurenine metabolic pathway as novel IL-6- independent mechanisms by which inflammation is propagated in the brain. The overall goal of this proposal is to validate and characterize these two putative mechanistic pathways by which GVHD induces inflammation in the brain and ascertain how they modulate systemic manifestations of this disease. Our overall hypothesis is that inflammation during GVHD is attributable to CNS resident macrophages which induce inflammation and behavioral dysfunction through both the endocannabinoid signaling and kynurenine metabolic pathways. Studies in Specific Aim 1 will define the effect of CB2R signaling blockade on CNS and systemic manifestations of GVHD. We will employ pharmacological and genetic approaches that directly antagonize CB2R receptor signaling or inhibit the synthesis of 2-AG, the natural endocannabinoid ligand of the CB2R, to address this question. Experiments in Specific Aim 2 will determine whether expression of the CB2R on CNS resident macrophages is critical for mediating GVHD-induced inflammation. We will utilize novel CB2Rfl/fl mice which have flanking lox p sites which will allow for cell-specific deletion when bred with appropriate lineage-specific Cre animals. Studies in Specific Aim 3 will define the role of the kynurenine pathway in the pathophysiology of CNS and systemic inflammation that occur during GVHD. We will determine whether CNS resident macrophages are the dominant source of neurotoxic kynurenine metabolites, and define whether inhibition of this pathway using both genetic and pharmacological approaches prevents inflammation in the brain and periphery. The overall goal is to define relevant biochemical and immunological pathways that are responsible for GVHD-associated neuroinflammation in order to foster the development of clinically relevant strategies to mitigate this complication in allogeneic HSCT patients with blood cancers.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2027 ( Subtotal = -$336 )
2027	2023	THE MEDICAL COLLEGE OF WISCONSIN, INC.	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	000	4	10/21/2026	NON-COMPETING CONTINUATION	-$336
														Subtotal = -$336

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	THE MEDICAL COLLEGE OF WISCONSIN, INC.	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	000	4	6/3/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $700,162 )
2023	2023	THE MEDICAL COLLEGE OF WISCONSIN, INC.	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	000	4	6/2/2023	NON-COMPETING CONTINUATION	$700,162
														Subtotal = $700,162

Issue Date FY: 2022 ( Subtotal = $700,162 )
2022	2022	MEDICAL COLLEGE OF WISCONSIN, INC., THE	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	000	3	5/25/2022	NON-COMPETING CONTINUATION	$700,162
														Subtotal = $700,162

Issue Date FY: 2021 ( Subtotal = $700,162 )
2021	2021	MEDICAL COLLEGE OF WISCONSIN, INC., THE	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	000	2	5/25/2021	NON-COMPETING CONTINUATION	$700,162
														Subtotal = $700,162

Issue Date FY: 2020 ( Subtotal = $695,482 )
2020	2020	MEDICAL COLLEGE OF WISCONSIN, INC., THE	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	000	1	7/10/2020	NEW	$686,566
2020	2020	MEDICAL COLLEGE OF WISCONSIN, INC., THE	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Blood Diseases and Resources Research	001	1	7/16/2020	NEW	$8,916
														Subtotal = $695,482

Grand Total All Awards = $2,795,632

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanistic Inflammatory Pathways in Graft Versus Host Disease

Award Number: R01HL154579

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2020

PERIOD OF PERFORMANCE END DATE: 05/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer